The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report.

Nakatsuji, Hideaki; Ikeda, Tetsuhiko; Hashizume, Atsushi; Katsuno, Masahisa; Sobue, Gen; Nakajima, Takashi

Nakatsuji, Hideaki; Ikeda, Tetsuhiko; Hashizume, Atsushi; Katsuno, Masahisa; Sobue, Gen; Nakajima, Takashi.

Afiliação

Nakatsuji H; Department of Clinical Research, National Hospital Organization Niigata National Hospital, Kashiwazaki, Japan.
Ikeda T; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hashizume A; Department of Neurology, National Hospital Organization Niigata National Hospital, Kashiwazaki, Japan.
Katsuno M; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Sobue G; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakajima T; Brain and Mind Research Center, Nagoya University, Nagoya, Japan.

Front Neurol ; 13: 905613, 2022.

Article em En | MEDLINE | ID: mdl-35812096

Palavras-chave

anti-androgen therapy; case report; creatine kinase; cybernic treatment; hybrid assistive limb; leuprorelin acetate; spinal and bulbar muscular atrophy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google